NEWS CENTER
Featured Stories
Janssen in the News
Press Releases
Mar 05, 2021
Canada
Johnson & Johnson COVID-19 Vaccine Granted Authorization under Interim Order by Health Canada For Emergency Use
Feb 28, 2021
United States
Johnson & Johnson Announces U.S. CDC Advisory Committee Recommends First Single-Shot COVID-19 Vaccine for Adults 18 and Older in U.S.
Feb 27, 2021
United States
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
Feb 26, 2021
United States
Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
Feb 24, 2021
United States
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA by ViiV Healthcare for Expanded Use of CABENUVA (rilpivirine and cabotegravir) as an HIV Treatment for Use Every Two Months
Feb 24, 2021
United States
Janssen to Highlight Latest Research on Multiple Sclerosis at ACTRIMS Forum 2021
Tweets
Janssen Global
@JanssenGlobal

-
We’re celebrating #IWD2021 by recognizing colleagues that #ChooseToChallenge the status quo to bring about positive… https://t.co/ehowjregqo
10 hours 27 min ago

Close
Art Gallery
We are proud to feature artwork created by people affected by the illnesses and diseases we are committed to treating and preventing.
View the Gallery